Professor Qiang Zhang
Chief Scientist of National "973" Key Basic Research Project
Deputy director of The State Key Laboratory of Natural and Biomimetic Drugs
Tel: +86-10-82802791
Fax: +86-10-82802791
E-mail:zqdodo@bjmu.edu.cn
Lab Website: http://sklnbd.bjmu.edu.cn/qianglab/
Dr. Qiang Zhang is a professor of Department of Pharmaceutics in School of Pharmaceutical Sciences, Peking University. He received his PhD degree in School of Pharmacy, West China University of Medical Sciences and joined the School of Pharmaceutical Sciences, Peking University in August 1992.
Research Interests
Molecular Pharmaceutics
Targeted Drug Delivery System
Combination Cancer Therapy
Nanotechnology
Honors/Awards
2011 Founder Teaching Award- Outstanding Teacher Award
2009 First Award for Achievements in Natural Science from Ministry of Education of China (the secondary accomplished people )
2008 First prize of the Jieping Wu-Paul Jansseen Prize
2008 First prize of The Science and Technology Award of Chinese Pharmaceutical Association
2007 Outstanding Talent Award from Ministry of Education of China
2003 Second Award for Achievements in Natural Science from Ministry of Education of China
2003 China Pharmaceutical Development Award
2000 Century Talent Fund Award for the Ministry of Education of China
Professional Service
Member of Drug Evaluation Committee of SFDA
The First President of China Chapter, Controlled Release Society
Chair of Pharmaceutics Committee,Chinese Pharmaceutical Association (CPA)
Member of the editorial board of Journal of Controlled release
Vice-Editor of Acta Pharma. Sinica and Chinese of Pharm. J
Vice Head of Pharmaceutics Committee, China pharmacopoeia
Board member of J Microencapulation
Lastest Publications
1. Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q*. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Control Release. 2011,152(3): 402-410
2. Wang Y, Yang T, Wang X, Dai W, Wang J, Zhang X, Li Z, Zhang Q*. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system. J Control Release. 2011,149 (3):299-306
3. Wang F, Zhang D*,Zhang Q*, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Biomaterials. 2011,32:9444-9456
4. Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q. Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature. Nanomedicine:NBM. 2011 May 20. [Epub ahead of print]
5. Zhang Y, Wang X, Wang J, Zhang X, Zhang Q. Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells. Pharm Res. 2011 May;28(5):1167-78. Epub 2011 Feb 22.
6. Jia Z, Lin P, Xiang Y, Wang X, Wang J, Zhang X, Zhang Q*. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. European J Pharma Biopharm. 2011,79(1):126-134
7. Zhang H, Hollis C P, Zhang Q*, Li T *. Preparation and antitumor study of camptothecin nanocrystals. Int J Pharma. 2011, 415 (1-2): 293-300
8. Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR, Zhang Q. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm. 2011 Aug 9. [Epub ahead of print]
9. Liu H, Liu Y*, Ma Z, Wang J, Zhang Q*. A Lipid Nanoparticle System Improves siRNA Efficacy in RPE Cells and a Laser-Induced Murine CNV Model. Invest Ophth Vis Sci, 2011, 52(7):4789-4794
